{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:36Z","timestamp":1772120016431,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Medical and Health Science and Technology Project of Zhejiang Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-022-01507-z","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T02:10:11Z","timestamp":1672798211000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association Between Serum Neurofilament Light Chain and Neurochemistry Deficits in Patients with Spinocerebellar Ataxia Type 3"],"prefix":"10.1007","volume":"23","author":[{"given":"Yuchao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouyao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqiu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiusi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenjuan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danning","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"1507_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng1194-221","volume":"8","author":"Y Kawaguchi","year":"1994","unstructured":"Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q321. Nature genetics. 1994;8:221\u20138.","journal-title":"Nature genetics"},{"key":"1507_CR2","first-page":"54","volume":"57","author":"P Maciel","year":"1995","unstructured":"Maciel P, Gaspar C, DeStefano AL, Silveira I, Coutinho P, et al. Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am J Hum Genet. 1995;57:54\u201361.","journal-title":"Am J Hum Genet"},{"key":"1507_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fneur.2019.00110","volume":"10","author":"X Yuan","year":"2019","unstructured":"Yuan X, Ou R, Hou Y, Chen X, Cao B, et al. Extra-cerebellar signs and non-motor features in chinese patients with spinocerebellar ataxia type 3. Front Neurol. 2019;10:110. https:\/\/doi.org\/10.3389\/fneur.2019.00110.","journal-title":"Front Neurol"},{"key":"1507_CR4","doi-asserted-by":"publisher","first-page":"e47479","DOI":"10.1371\/journal.pone.0047479","volume":"7","author":"P-S Wang","year":"2012","unstructured":"Wang P-S, Chen H-C, Wu H-M, Lirng J-F, Wu Y-T, Soong B-W. Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6. PLoS One. 2012;7:e47479. https:\/\/doi.org\/10.1371\/journal.pone.0047479.","journal-title":"PLoS One"},{"key":"1507_CR5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3389\/fneur.2019.01025","volume":"10","author":"H Peng","year":"2019","unstructured":"Peng H, Liang X, Long Z, Chen Z, Shi Y, et al. Gene-related cerebellar neurodegeneration in SCA3\/MJD: a case-controlled imaging-genetic study. Front Neurol. 2019;10:1025. https:\/\/doi.org\/10.3389\/fneur.2019.01025.","journal-title":"Front Neurol"},{"key":"1507_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40673-014-0017-4","volume":"1","author":"H-C Chen","year":"2014","unstructured":"Chen H-C, Lirng J-F, Soong B-W, Guo WY, Wu H-M, et al. The merit of proton magnetic resonance spectroscopy in the longitudinal assessment of spinocerebellar ataxias and multiple system atrophy-cerebellar type. Cerebellum Ataxias. 2014;1:17. https:\/\/doi.org\/10.1186\/s40673-014-0017-4.","journal-title":"Cerebellum Ataxias"},{"key":"1507_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0301-0082(95)00014-M","volume":"46","author":"G Tsai","year":"1995","unstructured":"Tsai G, Coyle JT. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol. 1995;46:531\u201340.","journal-title":"Prog Neurobiol"},{"key":"1507_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mrm.1910330109","volume":"33","author":"SM Oppenheimer","year":"1995","unstructured":"Oppenheimer SM, Bryan RN, Conturo TE, Soher BJ, Preziosi TJ, Barker PB. Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions. Magn Reson Med. 1995;33:61\u20138.","journal-title":"Magn Reson Med"},{"key":"1507_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ana.25264","volume":"84","author":"HS McLoughlin","year":"2018","unstructured":"McLoughlin HS, Moore LR, Chopra R, Komlo R, McKenzie M, et al. Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice. Ann Neurol. 2018;84:64\u201377. https:\/\/doi.org\/10.1002\/ana.25264.","journal-title":"Ann Neurol"},{"key":"1507_CR10","doi-asserted-by":"publisher","unstructured":"Hauser S, Helm J, Kraft M, Korneck M, H\u00fcbener-Schmid J and Sch\u00f6ls L. Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons. Mol Ther Nucleic Acids. 2022; 27. https:\/\/doi.org\/10.1016\/j.omtn.2021.11.015.","DOI":"10.1016\/j.omtn.2021.11.015"},{"key":"1507_CR11","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/mds.28140","volume":"35","author":"MdC Costa","year":"2020","unstructured":"Costa MdC, Radzwion M, McLoughlin HS, Ashraf NS, Fischer S, et al. In vivo molecular signatures of cerebellar pathology in spinocerebellar ataxia type 3. Mov Disord: official journal of the Movement Disorder Society. 2020;35:1774\u201386. https:\/\/doi.org\/10.1002\/mds.28140.","journal-title":"Mov Disord: official journal of the Movement Disorder Society"},{"key":"1507_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41398-021-01605-2","volume":"11","author":"L He","year":"2021","unstructured":"He L, Wang S, Peng L, Zhao H, Li S, et al. CRISPR\/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells. Transl Psychiatry. 2021;11:479. https:\/\/doi.org\/10.1038\/s41398-021-01605-2.","journal-title":"Transl Psychiatry"},{"key":"1507_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13024-019-0338-0","volume":"14","author":"Q-F Li","year":"2019","unstructured":"Li Q-F, Dong Y, Yang L, Xie J-J, Ma Y, et al. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3. Mol Neurodegener. 2019;14:39. https:\/\/doi.org\/10.1186\/s13024-019-0338-0.","journal-title":"Mol Neurodegener"},{"key":"1507_CR14","doi-asserted-by":"publisher","first-page":"e2977","DOI":"10.1212\/WNL.0000000000010671","volume":"95","author":"Y Peng","year":"2020","unstructured":"Peng Y, Zhang Y, Chen Z, Peng H, Wan N, et al. Association of serum neurofilament light and disease severity in patients with spinocerebellar ataxia type 3. Neurol. 2020;95:e2977\u201387. https:\/\/doi.org\/10.1212\/WNL.0000000000010671.","journal-title":"Neurol"},{"key":"1507_CR15","doi-asserted-by":"publisher","unstructured":"Garcia-Moreno H, Prudencio M, Thomas-Black G, Solanky N, Jansen-West KR, et al. Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3. Eur J Neurol. 2022. https:\/\/doi.org\/10.1111\/ene.15373","DOI":"10.1111\/ene.15373"},{"key":"1507_CR16","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s00415-018-8893-9","volume":"265","author":"C Wilke","year":"2018","unstructured":"Wilke C, Bender F, Hayer SN, Brockmann K, Sch\u00f6ls L, et al. Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study. J Neurol. 2018;265:1618\u201324. https:\/\/doi.org\/10.1007\/s00415-018-8893-9.","journal-title":"J Neurol"},{"key":"1507_CR17","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.neubiorev.2019.12.019","volume":"108","author":"J Krahe","year":"2020","unstructured":"Krahe J, Binkofski F, Schulz JB, Reetz K, Romanzetti S. Neurochemical profiles in hereditary ataxias: a meta-analysis of magnetic resonance spectroscopy studies. Neurosci Biobehav Rev. 2020;108:854\u201365. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.12.019.","journal-title":"Neurosci Biobehav Rev"},{"key":"1507_CR18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","volume":"87","author":"JD Rohrer","year":"2016","unstructured":"Rohrer JD, Woollacott IOC, Dick KM, Brotherhood E, Gordon E, et al. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurol. 2016;87:1329\u201336. https:\/\/doi.org\/10.1212\/WNL.0000000000003154.","journal-title":"Neurol"},{"key":"1507_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.brat.2016.11.001","volume":"98","author":"AF Hayes","year":"2017","unstructured":"Hayes AF, Rockwood NJ. Regression-based statistical mediation and moderation analysis in clinical research: observations, recommendations, and implementation. Behav Res Ther. 2017;98:39\u201357. https:\/\/doi.org\/10.1016\/j.brat.2016.11.001.","journal-title":"Behav Res Ther"},{"key":"1507_CR20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/mds.26181","volume":"30","author":"IM Adanyeguh","year":"2015","unstructured":"Adanyeguh IM, Henry P-G, Nguyen TM, Rinaldi D, Jauffret C, et al. In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7. Mov Disord: official journal of the Movement Disorder Society. 2015;30:662\u201370. https:\/\/doi.org\/10.1002\/mds.26181.","journal-title":"Mov Disord: official journal of the Movement Disorder Society"},{"key":"1507_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nicl.2016.11.007","volume":"13","author":"S-R Huang","year":"2017","unstructured":"Huang S-R, Wu Y-T, Jao C-W, Soong B-W, Lirng J-F, et al. CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3. Neuroimage Clin. 2017;13:97\u2013105. https:\/\/doi.org\/10.1016\/j.nicl.2016.11.007.","journal-title":"Neuroimage Clin"},{"key":"1507_CR22","doi-asserted-by":"publisher","first-page":"e47925","DOI":"10.1371\/journal.pone.0047925","volume":"7","author":"J-F Lirng","year":"2012","unstructured":"Lirng J-F, Wang P-S, Chen H-C, Soong B-W, Guo WY, et al. Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy. PLoS One. 2012;7:e47925. https:\/\/doi.org\/10.1371\/journal.pone.0047925.","journal-title":"PLoS One"},{"key":"1507_CR23","doi-asserted-by":"publisher","first-page":"105311","DOI":"10.1016\/j.nbd.2021.105311","volume":"153","author":"G Coarelli","year":"2021","unstructured":"Coarelli G, Darios F, Petit E, Dorgham K, Adanyeguh I, et al. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia. Neurobiol Dis. 2021;153:105311. https:\/\/doi.org\/10.1016\/j.nbd.2021.105311.","journal-title":"Neurobiol Dis"},{"key":"1507_CR24","doi-asserted-by":"publisher","first-page":"e11803","DOI":"10.15252\/emmm.201911803","volume":"12","author":"C Wilke","year":"2020","unstructured":"Wilke C, Haas E, Reetz K, Faber J, Garcia-Moreno H, et al. Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice. EMBO Mol Med. 2020;12:e11803. https:\/\/doi.org\/10.15252\/emmm.201911803.","journal-title":"EMBO Mol Med"},{"key":"1507_CR25","doi-asserted-by":"publisher","first-page":"e671","DOI":"10.1212\/WNL.0000000000011226","volume":"96","author":"I Ill\u00e1n-Gala","year":"2021","unstructured":"Ill\u00e1n-Gala I, Lleo A, Karydas A, Staffaroni AM, Zetterberg H, et al. Plasma Tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer disease. Neurol. 2021;96:e671\u201383. https:\/\/doi.org\/10.1212\/WNL.0000000000011226.","journal-title":"Neurol"},{"key":"1507_CR26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S1474-4422(19)30354-0","volume":"18","author":"EL van der Ende","year":"2019","unstructured":"van der Ende EL, Meeter LH, Poos JM, Panman JL, Jiskoot LC, et al. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study. Lancet Neurol. 2019;18:1103\u201311. https:\/\/doi.org\/10.1016\/S1474-4422(19)30354-0.","journal-title":"Lancet Neurol"},{"key":"1507_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jalz.2019.09.004","volume":"16","author":"FM Elahi","year":"2020","unstructured":"Elahi FM, Casaletto KB, La Joie R, Walters SM, Harvey D, et al. Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer\u2019s disease. Alzheimers Dement. 2020;16:681\u201395. https:\/\/doi.org\/10.1016\/j.jalz.2019.09.004.","journal-title":"Alzheimers Dement"},{"key":"1507_CR28","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/mds.28779","volume":"36","author":"WW Aamodt","year":"2021","unstructured":"Aamodt WW, Waligorska T, Shen J, Tropea TF, Siderowf A, et al. Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease. Mov Disord: official journal of the Movement Disorder Society. 2021;36:2945\u201350. https:\/\/doi.org\/10.1002\/mds.28779.","journal-title":"Mov Disord: official journal of the Movement Disorder Society"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01507-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-022-01507-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01507-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T09:05:57Z","timestamp":1708160757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-022-01507-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["1507"],"URL":"https:\/\/doi.org\/10.1007\/s12311-022-01507-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2132253\/v1","asserted-by":"object"}]},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"assertion":[{"value":"20 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}